On February 27, 2025 BioInvent reported year-end report January 1 to December 31, 2024 (Presentation, BioInvent, FEB 27, 2025, https://www.bioinvent.com/sites/bioinvent/files/pr/20250227-92fc1f95-a930-49cc-a48b-32c70e35f4c8-1.pdf?ts=1740639699 [SID1234652093]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!